The first human clinical trial to preliminarily evaluate the safety and efficacy of cellular therapy with mesenchymal stem cells for the corneal stroma has shown promise.
Dr Jorge L. Alió del Barrio
Advertisement
Articles by Dr Jorge L. Alió del Barrio
Advertisement
Latest Updated Articles
- Cellular therapy of the corneal stroma: Real approach or science fiction?
Published: January 8th 2018 | Updated:
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: New horizons in research and risk management for ROP
2
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
3
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
4
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
5
